UPDATE: JMP Securities Upgrades Iovanace Biotherapeutics (IOVA) to Market Outperform; Data at ASCO 'Looks Impressive'
Tweet Send to a Friend
(Updated - June 10, 2021 6:47 AM EDT)
JMP Securities analyst Reni J. Benjamin upgraded Iovanace Biotherapeutics (NASDAQ: IOVA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JMP Securities analyst Reni J. Benjamin upgraded Iovanace Biotherapeutics (NASDAQ: IOVA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
